In Vivo Models
Preclinical Research Services:
In Vivo Disease Models
MLM Medical Labs, your trusted research partner with over a decade of expertise in preclinical inflammation and immunology, supports biotech and pharma companies in advancing innovations through meticulously executed studies designed for translatability.
MLM’s preclinical services encompass a comprehensive range of in vivo GLP and non-GLP studies to assess your drug development or therapy requirements for early-stage drug discovery as well as advanced therapy development. Explore our ever growing portfolio of 60+ customizable in vivo models, addressing various diseases including fibrosis models, arthritis models, respiratory models, dermal models, inflammatory disease models, and sepsis models.
Our in vivo models serve as a foundation for biomarker analysis, allowing evaluation of compound effects at each disease stage. MLM’s diverse readout parameter profile offers key insights into your candidate’s therapeutic impact. Our team of expert scientists become accessible partners throughout the entirety of your project, ensuring you are in the loop from study inception until completion and reporting.
Areas of study include, but are not limited to:
MLM Medical Labs proudly offers an extensive range of biomarker services, leveraging cutting-edge platforms such as ELISA, Multiplex, Flow Cytometry, and qPCR. What sets us apart is in-house ex vivo capabilities, allowing us to conduct vital experiments onsite. This streamlined approach eliminates the hassle of dealing with multiple vendors, safeguarding sample integrity and offering unparalleled convenience. Moreover, our expertise in histology enhances our comprehensive suite of services, providing invaluable insights into tissue analysis.
Partner with MLM Medical Labs to seamlessly navigate preclinical development and propel your drug initiatives forward with confidence.
Explore our capabilities further:
Are you interested in a variation of a model or a new paradigm?
Our scientists are passionate about the development of new models! We often participate in opportunities for co-development and pilot programs to establish new models and reach new levels of understanding.